title: Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia.
abstract: OBJECTIVE
  Taurine as an endogenous substance possesses a number of cytoprotective properties. In the study, we have evaluated the neuroprotective effect of taurine and investigated whether taurine exerted neuroprotection through affecting calpain/calpastatin or caspase-3 actions during focal cerebral ischemia, since calpain and caspase-3 play central roles in ischemic neuronal death.
  
  
  METHODS
  Male Sprague-Dawley rats were subjected to 2 h of middle cerebral artery occlusion (MCAo), and 22 h of reperfusion. Taurine was administrated intravenously 1 h after MCAo. The dose-responses of taurine to MCAo were determined. Next, the effects of taurine on the activities of calpain, calpastatin and caspase-3, the levels of calpastatin, microtubule-associated protein-2 (MAP-2) and alphaII-spectrin, and the apoptotic cell death in penumbra were evaluated.
  
  
  RESULTS
  Taurine reduced neurological deficits and decreased the infarct volume 24 h after MCAo in a dose-dependent manner. Treatment with 50 mg/kg of taurine significantly increased the calpastatin protein levels and activities, and markedly reduced the m-calpain and caspase-3 activities in penumbra 24 h after MCAo, however, it had no significant effect on mu-calpain activity. Moreover, taurine significantly increased the MAP-2 and alphaII-spectrin protein levels, and markedly reduced the ischemia-induced TUNEL staining positive score within penumbra 24 h after MCAo.
  
  
  CONCLUSIONS
  Our data demonstrate the dose-dependent neuroprotection of taurine against transient focal cerebral ischemia, and suggest that one of protective mechanisms of taurine against ischemia may be blocking the m-calpain and caspase-3-mediated apoptotic cell death pathways.
authors: Department of Neurochemistry, Beijing Neurosurgical Institute, 6 Tiantan Xi Li, 100050 Beijing, PR China.
authors: Ming
authors: M
authors: Sun
authors: Chao
authors: C
authors: Xu
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002154:Calpain / Q000378:metabolism* / Q000494:pharmacology*; D053148:Caspase 3 / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects; D004789:Enzyme Activation / Q000187:drug effects; D008297:Male; D008840:Microfilament Proteins / Q000378:metabolism; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D008954:Models, Biological; D018696:Neuroprotective Agents / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013654:Taurine / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects; D033921:Vesicular Transport Proteins / Q000378:metabolism
chemical_list: D002135:Calcium-Binding Proteins; D008840:Microfilament Proteins; D008869:Microtubule-Associated Proteins; D018696:Neuroprotective Agents; C422208:Sptan1 protein, rat; D033921:Vesicular Transport Proteins; D013654:Taurine; C033668:calpastatin; D002154:Calpain; D053148:Caspase 3
references: Neurochem Res. 2002 Feb;27(1-2):21-6
references: 11926272
references: Apoptosis. 2003 Aug;8(4):353-61
references: 12815278
references: Biochem Pharmacol. 1995 Nov 27;50(11):1783-93
references: 8615856
references: Curr Opin Cell Biol. 1990 Feb;2(1):51-6
references: 2183842
references: Life Sci. 1987 May 25;40(21):2059-66
references: 3586851
references: Brain Res. 2005 Apr 8;1040(1-2):36-43
references: 15804424
references: J Cell Biol. 1992 Nov;119(3):493-501
references: 1400587
references: Altern Med Rev. 1998 Apr;3(2):128-36
references: 9577248
references: Arch Biochem Biophys. 1998 Aug 15;356(2):187-96
references: 9705209
references: J Neurochem. 1974 May;22(5):871-2
references: 4407108
references: Stroke. 1998 Oct;29(10):2162-70
references: 9756599
references: Exp Eye Res. 1987 Dec;45(6):769-76
references: 3428399
references: J Neurochem. 2006 Jul;98(1):310-20
references: 16805817
references: FASEB J. 2004 Mar;18(3):511-8
references: 15003996
references: Stroke. 1998 May;29(5):1037-46; discussion 1047
references: 9596255
references: Adv Exp Med Biol. 2003;526:527-36
references: 12908639
references: Biochem J. 1996 Nov 1;319 ( Pt 3):683-90
references: 8920967
references: Exp Brain Res. 1992;89(1):67-78
references: 1601103
references: Brain Res. 1984 May 7;299(1):103-12
references: 6144366
references: Physiol Rev. 2003 Jul;83(3):731-801
references: 12843408
references: J Biol Chem. 2006 Jan 6;281(1):229-40
references: 16234245
references: Stroke. 1993 Jan;24(1):117-21
references: 8418534
references: J Neurochem. 1991 May;56(5):1630-8
references: 2013758
references: Hippocampus. 1993;3 Spec No:61-71
references: 8287113
references: Stroke. 2002 Aug;33(8):2123-36
references: 12154275
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: Br J Neurosurg. 1996 Oct;10(5):483-7
references: 8922708
references: Adv Exp Med Biol. 2000;483:1-25
references: 11787586
references: J Cereb Blood Flow Metab. 1990 Mar;10(2):290-3
references: 1689322
references: Biochim Biophys Acta. 1993 Sep 8;1182(2):215-20
references: 8357852
references: Adv Exp Med Biol. 2003;526:421-31
references: 12908627
references: NeuroRx. 2004 Jan;1(1):36-45
references: 15717006
references: Neuroscience. 1998 Mar;83(2):449-58
references: 9460753
references: J Neurosci Res. 1981;6(4):465-74
references: 7299851
references: Arch Biochem Biophys. 1995 May 10;319(1):211-6
references: 7771786
references: J Neurosci. 2001 Sep 15;21(18):7127-34
references: 11549723
references: J Cereb Blood Flow Metab. 1996 Jan;16(1):170-4
references: 8530550
references: Amino Acids. 2000;19(3-4):509-26
references: 11140356
references: Biol Pharm Bull. 1993 Oct;16(10):970-2
references: 8287047
references: J Neurosci. 2003 May 15;23(10):4081-91
references: 12764095
references: J Med Food. 2006 Spring;9(1):33-41
references: 16579726
references: Cerebrovasc Dis. 2006;21 Suppl 2:1-8
references: 16651809
references: Neurosci Res. 2003 Dec;47(4):373-82
references: 14630341
references: Biochem Pharmacol. 1999 Oct 1;58(7):1123-31
references: 10484070
references: J Biol Chem. 1999 May 14;274(20):14046-52
references: 10318818
references: Cell. 1997 Nov 14;91(4):443-6
references: 9390553
references: Adv Exp Med Biol. 2000;483:411-29
references: 11787627
references: Physiol Rev. 1992 Jan;72(1):101-63
references: 1731369
references: Clin Neuropharmacol. 1983 Mar;6(1):37-48
references: 6342765
references: J Pharmacol Exp Ther. 2006 May;317(2):529-36
references: 16467455
references: J Biochem. 1997 Oct;122(4):743-8
references: 9399577
references: Adv Exp Med Biol. 1994;359:289-98
references: 7887268
references: J Biol Chem. 1998 Jul 10;273(28):17559-64
references: 9651349
references: Amino Acids. 2004 Mar;26(2):111-6
references: 15042438
references: Neuroscience. 2002;115(1):125-36
references: 12401327
references: Brain Res. 1998 Nov 9;810(1-2):181-99
references: 9813316
references: Stroke. 1998 Mar;29(3):705-18
references: 9506616
references: Adv Exp Med Biol. 1996;403:445-54
references: 8915382
references: Neurochem Res. 2004 Jan;29(1):117-26
references: 14992270
references: NeuroRx. 2004 Jan;1(1):46-70
references: 15717007
references: Adv Exp Med Biol. 1996;403:223-32
references: 8915359
references: Neurosci Lett. 1980 Mar;16(3):297-300
references: 7052443
references: Endocrine. 2006 Apr;29(2):217-31
references: 16785598
references: J Cereb Blood Flow Metab. 1998 Oct;18(10):1071-6
references: 9778183
references: Cell Tissue Res. 2000 Jul;301(1):173-87
references: 10928290
references: Trends Neurosci. 2003 May;26(5):248-54
references: 12744841
references: Neurochem Res. 2004 Jan;29(1):189-97
references: 14992278
references: Neurochem Res. 1978 Feb;3(1):115-23
references: 683411
references: Am J Physiol. 1986 Mar;250(3 Pt 1):C347-60
references: 3082216
references: Adv Exp Med Biol. 2003;526:515-25
references: 12908638
references: Physiol Rev. 1999 Oct;79(4):1431-568
references: 10508238